ContraFect

ContraFect Debt-to-Equity

The Debt-to-Equity Ratio of ContraFect (CFRXQ) as of Nov 8, 2026 is -0.24. In the previous year, Debt-to-Equity Ratio was 0.07 — a change of -467.49% (lower).

Debt-to-Equity

-0.24

YoY

-467.49%

Last updated:

Debt-to-Equity Ratio of ContraFect is 2022 -0.24 . Debt-to-Equity Ratio of ContraFect was 2021 0.07 . It decreases by -467.49% lower compared to the previous year.

The ContraFect Debt-to-Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt-to-Equity
Date
Debt-to-Equity
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
Jan 1, 2019
0.25 USD
Jan 1, 2020
0.29 USD
Jan 1, 2021
0.07 USD
Jan 1, 2022
-0.24 USD
The ContraFect Debt-to-Equity history
YEARDebt-to-EquityYoY
-0.24-467.49%
0.07-76.83%
0.29+13.92%
0.25—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Debt-to-Equity Ratio of ContraFect is -0.24 in 2022.

Debt-to-Equity Ratio of ContraFect changed from 0.07 to -0.24, representing a -467.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Equity Ratio ContraFect since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholders' equity. Higher ratios indicate more debt financing relative to equity.

Debt/Equity = Total Debt / Shareholders' Equity

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Equity Ratio's ContraFect with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ContraFect

All Key Metrics — ContraFect